Atlas Trials

Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer

Clinical trial NCT00423917 · COMPLETED

Trial details

NCT number
NCT00423917
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2007-08-01
Primary completion
2009-02-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.